Drug Profile
DTaP poliovirus vaccine - KM Biologics
Alternative Names: DTaP-IPV combination vaccine- KM Biologics; KD 332Latest Information Update: 28 Aug 2019
Price :
$50
*
At a glance
- Originator Kaketsuken
- Developer KM Biologics
- Class Bacterial vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Diphtheria; Pertussis; Poliomyelitis; Tetanus
Most Recent Events
- 28 Aug 2019 Discontinued - Phase-III for Diphtheria (In children, In infants, Prevention, In volunteers) in Japan (SC)
- 28 Aug 2019 Discontinued - Phase-III for Pertussis (In children, In infants, Prevention, In volunteers) in Japan (SC)
- 28 Aug 2019 Discontinued - Phase-III for Poliomyelitis (In children, In infants, Prevention, In volunteers) in Japan (SC)